Literature DB >> 11086643

Renal symptomatology in patients with acute intermittent porphyria. A population-based study.

C Andersson1, A Wikberg, B Stegmayr, F Lithner.   

Abstract

OBJECTIVE: Can renal insufficiency in subjects with acute intermittent porphyria (AIP) be due solely to
DESIGN: A population-based study.
SUBJECTS: Subjects with AIP > or = 18 years of age (n = 386) in the four most northerly counties of Sweden.
INTERVENTIONS: Screening with creatinine clearance at 24 h. Patients below the lower reference level underwent a repeat clearance test and, if still low, also chromEDTA clearance.
RESULTS: 286 (74%) subjects performed the creatinine clearance test and in 57 clearance was low; the second clearance proved normal in 23 who were then excluded. Eighteen subjects with other possible medical reasons for renal insufficiency, ethical reasons or refusing further examinations were also excluded. The 16 remaining subjects with no explanation for their renal insufficiency other than AIP were then studied in detail. All 14 women, mean age 52 years, and two uraemic men, 58 and 67 years, had manifest AIP. Twelve patients had hypertension (HT) and four were normotensive in spite of renal insufficiency. Histological findings of renal biopsies revealed diffuse glomerulosclerotic and interstitial changes with additional ischaemic lesions.
CONCLUSION: Protracted vasospasm in attacks of AIP may be a cause of renal lesions. This is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086643     DOI: 10.1046/j.1365-2796.2000.00743.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  13 in total

1.  High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.

Authors:  Nicolas Pallet; Iadh Mami; Caroline Schmitt; Zoubida Karim; Arnaud François; Marion Rabant; Dominique Nochy; Laurent Gouya; Jean-Charles Deybach; Yichum Xu-Dubois; Eric Thervet; Hervé Puy; Alexandre Karras
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

Review 2.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

Review 3.  Acute hepatic porphyrias: Recommendations for evaluation and long-term management.

Authors:  Manisha Balwani; Bruce Wang; Karl E Anderson; Joseph R Bloomer; D Montgomery Bissell; Herbert L Bonkovsky; John D Phillips; Robert J Desnick
Journal:  Hepatology       Date:  2017-09-04       Impact factor: 17.425

Review 4.  The acute hepatic porphyrias.

Authors:  Bruce Wang
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

Review 5.  Liver transplantation in the management of porphyria.

Authors:  Ashwani K Singal; Charles Parker; Christine Bowden; Manish Thapar; Lawrence Liu; Brendan M McGuire
Journal:  Hepatology       Date:  2014-07-29       Impact factor: 17.425

6.  Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis.

Authors:  Joanna K Dowman; Bridget K Gunson; Darius F Mirza; Simon R Bramhall; Mike N Badminton; Philip N Newsome
Journal:  Liver Transpl       Date:  2012-02       Impact factor: 5.799

7.  Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse.

Authors:  Carmen Unzu; Ana Sampedro; Eliane Sardh; Itsaso Mauleón; Rafael Enríquez de Salamanca; Jesús Prieto; Eduardo Salido; Pauline Harper; Antonio Fontanellas
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

8.  Medical and financial burden of acute intermittent porphyria.

Authors:  Rochus A Neeleman; Margreet A E M Wagenmakers; Rita H Koole-Lesuis; G Sophie Mijnhout; J H Paul Wilson; Edith C H Friesema; Janneke G Langendonk
Journal:  J Inherit Metab Dis       Date:  2018-04-19       Impact factor: 4.982

9.  Variegate porphyria complicated by systemic AA amyloidosis: a case report.

Authors:  Yoshiki Tsuchiya; Junichi Hoshino; Tatsuya Suwabe; Keiichi Sumida; Rikako Hiramatsu; Koki Mise; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Hayami; Naoki Sawa; Kenji Arizono; Shigeko Hara; Kenmei Takaichi; Takeshi Fujii; Yoshifumi Ubara
Journal:  Amyloid       Date:  2013-10-16       Impact factor: 7.141

10.  Porphyria: What Is It and Who Should Be Evaluated?

Authors:  Yonatan Edel; Rivka Mamet
Journal:  Rambam Maimonides Med J       Date:  2018-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.